MetaVia is trading at $1.36, up 10.54%, with no identified catalyst for the October 20 pre-market rise.
- No new company-specific announcement explaining the move was found. The latest company news located was the October 13 appointment of Sarah Browne as Chief Medical Officer.
- The Nasdaq was down 0.60% in the supplied market context, which does not clearly explain the upward move.